News Image

GILEAD SCIENCES INC (NASDAQ:GILD) – A Quality Stock Worth Considering

By Mill Chart

Last update: Jun 20, 2025

GILEAD SCIENCES INC (NASDAQ:GILD) was identified through our Caviar Cruise quality investing screen, which focuses on companies with strong fundamentals, profitability, and financial health. GILD stands out for its high return on capital, solid cash flow generation, and reasonable valuation, making it a candidate for long-term investors. Below, we examine why this biopharmaceutical firm fits the criteria for quality investing.

GILEAD SCIENCES stock chart

Key Strengths of GILEAD SCIENCES INC

  • High Return on Invested Capital (ROICexgc): GILD’s ROIC of 97.64% (excluding cash, goodwill, and intangibles) is exceptional, indicating efficient use of capital to generate profits. This places it well above industry peers.
  • Strong EBIT Growth: The company’s 5-year EBIT growth rate of 19.42% outpaces its revenue growth, signaling improving operational efficiency and pricing power.
  • Healthy Debt Management: With a Debt-to-Free Cash Flow ratio of 2.53, GILD could repay its debt in under three years using current cash flows, reflecting financial stability.
  • Profit Quality: A 5-year average profit quality of 1,749.07% (Free Cash Flow to Net Income) suggests the company converts earnings into cash effectively, a key trait for quality businesses.
  • Attractive Valuation: GILD trades at a P/E of 13.95, below both the industry average and the S&P 500, making it reasonably priced despite strong fundamentals.

Fundamental Analysis Summary

Our report assigns GILD a fundamental rating of 6/10, highlighting its profitability and value characteristics. Key takeaways:

  • Profitability: High margins (Operating Margin of 38.17%) and strong returns on equity (31.13%) demonstrate operational strength.
  • Dividend: A 2.82% yield with a stable payout history, though the payout ratio is slightly high at 66%.
  • Growth: While past revenue growth has been modest (3.51% 5-year CAGR), earnings are expected to grow by 17.75% annually in the coming years.
  • Financial Health: A manageable debt load, though liquidity ratios (Current Ratio of 1.37) are below industry averages.

For investors seeking quality stocks with a mix of profitability, cash flow strength, and reasonable valuation, GILD presents a compelling case.

Our Caviar Cruise screener lists more quality stocks and is updated regularly.

Disclaimer

This is not investing advice. Always conduct your own research before making investment decisions.

GILEAD SCIENCES INC

NASDAQ:GILD (7/11/2025, 3:37:07 PM)

110.1

-4.44 (-3.88%)



Find more stocks in the Stock Screener

GILD Latest News and Analysis

ChartMill News Imagean hour ago - ChartmillTop S&P500 movers in Friday's session

Uncover the latest developments among S&P500 stocks in today's session. Stay tuned to the S&P500 index's top gainers and losers on Friday.

Mentions: CF HAL ALB VTR ...

ChartMill News Image3 hours ago - ChartmillWhat's going on in today's session: S&P500 movers

Let's have a look at the top S&P500 gainers and losers in the middle of the day of today's session.

Mentions: HAL SLB ALB GE ...

ChartMill News Image4 days ago - ChartmillGILEAD SCIENCES INC (NASDAQ:GILD) - A Strong Technical Setup for Breakout Investors

GILEAD SCIENCES INC (NASDAQ:GILD) shows strong technicals and a high-quality breakout setup, making it a stock to watch for momentum traders.

Follow ChartMill for more